Cargando…
CYP26A1 Is a Novel Biomarker for Betel Quid-Related Oral and Pharyngeal Cancers
Betel quid (BQ) has been classified as a Group I human carcinogen in light of evidence demonstrating an association with an elevated risk of oral and pharyngeal cancers. To date, the incidence rate of oral and pharynx cancers among Taiwanese men ranks the highest worldwide. However, no study has yet...
Autores principales: | Chen, Ping-Ho, Chung, Chia-Min, Wang, Yen-Yun, Huang, Hurng-Wern, Huang, Bin, Lee, Ka-Wo, Yuan, Shyng-Shiou, Wu, Che-Wei, Lin, Lee-Shuan, Chan, Leong-Perng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700252/ https://www.ncbi.nlm.nih.gov/pubmed/33233443 http://dx.doi.org/10.3390/diagnostics10110982 |
Ejemplares similares
-
Expression of a Splice Variant of CYP26B1 in Betel Quid-Related Oral Cancer
por: Chen, Ping-Ho, et al.
Publicado: (2014) -
Adverse Health Effects of Betel Quid and the Risk of Oral and Pharyngeal Cancers
por: Chen, Ping-Ho, et al.
Publicado: (2017) -
The Influence of Monoamine Oxidase Variants on the Risk of Betel Quid-Associated Oral and Pharyngeal Cancer
por: Chen, Ping-Ho, et al.
Publicado: (2014) -
Effects of DSM-5 Betel-Quid-Related Symptoms, Pathological Behaviors, and Use Disorder on Oral Squamous Cell Carcinoma Risk
por: Wang, Wen-Chen, et al.
Publicado: (2022) -
Association Study between Novel CYP26 Polymorphisms and the Risk of Betel Quid-Related Malignant Oral Disorders
por: Wu, Shyh-Jong, et al.
Publicado: (2015)